Amundi »

Summit Therapeutics shares owned by Amundi

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Amundi

Quarter filed Position value Share count Share price at filing
2025-09-30 $310k 14k 22.15
2025-06-30 $258k 11k 22.62
2024-12-31 $1.1k 58 18.83